Compare EIG & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | EIG | CBLL |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 754.0M | 750.1M |
| IPO Year | 2006 | N/A |
| Metric | EIG | CBLL |
|---|---|---|
| Price | $41.95 | $16.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.20 |
| AVG Volume (30 Days) | 163.0K | ★ 285.3K |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $858,700,000.00 | N/A |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | $1.26 | $28.44 |
| P/E Ratio | $79.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.73 | $10.85 |
| 52 Week High | $49.91 | $24.33 |
| Indicator | EIG | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 31.17 |
| Support Level | $41.08 | $11.17 |
| Resistance Level | $43.19 | $20.25 |
| Average True Range (ATR) | 1.11 | 1.10 |
| MACD | -0.08 | -0.52 |
| Stochastic Oscillator | 64.90 | 9.80 |
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.